Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN107365264A reveals a novel NIS-oxidized route for sulfonamide synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel ultrasonic-assisted method for gemfibrozil intermediate ensures high purity and yield. Reliable supply chain partner for pharmaceutical manufacturing cost reduction and scalability.
Patent CN106831603A reveals a visible-light promoted, transition-metal-free synthesis of perfluoroalkylpyrimidines, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN113214094A details a novel 11-step voglibose synthesis from glucose, offering significant cost reduction in API manufacturing through mild conditions and high yields.
Discover the novel 5-step synthesis for Roflumilast intermediate I. Enhanced yield, no chromatography, and scalable industrial production for global supply chains.
Patent CN117448309A reveals biocatalytic synthesis for high-purity pregabalin intermediates. Achieve significant cost reduction and supply chain reliability.
Patent CN111778229B reveals high-efficiency hydrolase mutants for >99% ee production. Ideal for reliable pharma intermediate supply chains.
Novel Ti-Ni catalytic method for allyl alcohol compounds reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Novel esterase mutant enables high-yield chiral intermediate production. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Patent CN105732413B reveals ligand-free copper catalysis for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN101012141B reveals catalytic oxidation for high-purity PPIs. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Advanced peptide purification using PS-DVB chromatography ensures high purity and scalable production for octreotide acetate manufacturing supply chains.
Novel MnO2 oxidation method ensures high purity Pitavastatin Calcium 5-oxo impurity for pharmaceutical analysis and supply chain stability. Reliable sourcing for quality control standards.
Patent CN104651243A reveals a biocatalytic route for (R)-1,3-butanediol. Offers high purity and yield for antibiotic synthesis, ensuring reliable supply chain solutions.
Patent CN109384746A reveals a direct synthesis route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for global buyers.
Novel synthesis route for Safinamide intermediate offering high purity and yield improvements for pharmaceutical supply chains and cost reduction.
Patent CN106748971B details a high-yield synthesis for K opioid receptor ligand intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN106868534B enables mild electro-catalytic synthesis. Delivers high-purity bile acids with substantial cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN101676296B details a novel method for 21-position carboxylate steroids. Offers cost reduction in pharmaceutical intermediates manufacturing and scalable routes for anticancer drug development.
Patent CN119823958A details a ketoreductase mutant for synthesizing chiral intermediates. This report analyzes supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.